The blood-brain barrier transmigrating single domain antibody: mechanisms of transport and antigenic epitopes in human brain endothelial cells

被引:159
作者
Abulrob, A
Sprong, H
Henegouwen, PVBE
Stanimirovic, D
机构
[1] Natl Res Council Canada, Cerebrovasc Res Grp, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada
[2] Univ Utrecht, Biomembrane Inst, Dept Mol Cell Biol, Utrecht, Netherlands
关键词
blood-brain barrier; glycocalyx; receptor-mediated endocytosis; sialic acid; single domain antibodies; transcytosis;
D O I
10.1111/j.1471-4159.2005.03463.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Antibodies against receptors that undergo transcytosis across the blood-brain barrier (BBB) have been used as vectors to target drugs or therapeutic peptides into the brain. We have recently discovered a novel single domain antibody, FC5, which transmigrates across human cerebral endothelial cells in vitro and the BBB in vivo. The purpose of this study was to characterize mechanisms of FC5 endocytosis and transcytosis across the BBB and its putative receptor on human brain endothelial cells. The transport of FC5 across human brain endothelial cells was polarized, charge independent and temperature dependent, suggesting a receptor-mediated process. FC5 taken up by human brain endothelial cells co-localized with clathrin but not with caveolin-1 by immunochemistry and was detected in clathrin-enriched subcellular fractions by western blot. The transendothelial migration of FC5 was reduced by inhibitors of clathrin-mediated endocytosis, K+ depletion and chlorpromazine, but was insensitive to caveolae inhibitors, filipin, nystatin or methyl-beta-cyclodextrin. Following internalization, FC5 was targeted to early endosomes, bypassed late endosomes/lysosomes and remained intact after transcytosis. The transcytosis process was inhibited by agents that affect actin cytoskeleton or intracellular signaling through PI3-kinase. Pretreatment of human brain endothelial cells with wheatgerm agglutinin, sialic acid, alpha(2,3)-neuraminidase or Maackia amurensis agglutinin that recognizes alpha(2,3)-, but not with Sambucus nigra agglutinin that recognizes alpha(2,6) sialylgalactosyl residues, significantly reduced FC5 transcytosis. FC5 failed to recognize brain endothelial cells-derived lipids, suggesting that it binds luminal alpha(2,3)-sialoglycoprotein receptor which triggers clathrin-mediated endocytosis. This putative receptor may be a new target for developing brain-targeting drug delivery vectors.
引用
收藏
页码:1201 / 1214
页数:14
相关论文
共 72 条
  • [1] Transporting therapeutics across the blood-brain barrier
    Abbott, NJ
    Romero, IA
    [J]. MOLECULAR MEDICINE TODAY, 1996, 2 (03): : 106 - 113
  • [2] Single domain antibodies as blood-brain barrier delivery vectors
    Abulrob, A
    Zhang, JB
    Tanha, J
    MacKenzie, R
    Stanimirovic, D
    [J]. DRUG TRANSPORT(ERS) AND THE DISEASED BRAIN, 2005, 1277 : 212 - 223
  • [3] Interactions of EGFR and caveolin-1 in human glioblastoma cells: evidence that tyrosine phosphorylation regulates EGFR association with caveolae
    Abulrob, A
    Giuseppin, S
    Andrade, MF
    McDermid, A
    Moreno, M
    Stanimirovic, D
    [J]. ONCOGENE, 2004, 23 (41) : 6967 - 6979
  • [4] SYNTHESIS AND EXPRESSION IN ESCHERICHIA-COLI OF CISTRONIC DNA ENCODING AN ANTIBODY FRAGMENT SPECIFIC FOR A SALMONELLA SEROTYPE-B O-ANTIGEN
    ANAND, NN
    DUBUC, G
    PHIPPS, J
    MACKENZIE, CR
    SADOWSKA, J
    YOUNG, NM
    BUNDLE, DR
    NARANG, SA
    [J]. GENE, 1991, 100 : 39 - 44
  • [5] Proteoglycans in the developing brain: New conceptual insights for old proteins
    Bandtlow, CE
    Zimmermann, DR
    [J]. PHYSIOLOGICAL REVIEWS, 2000, 80 (04) : 1267 - 1290
  • [6] Banks WA, 1998, J CELL SCI, V111, P533
  • [7] MONENSIN INTERRUPTS THE RECYCLING OF LOW-DENSITY LIPOPROTEIN RECEPTORS IN HUMAN-FIBROBLASTS
    BASU, SK
    GOLDSTEIN, JL
    ANDERSON, RGW
    BROWN, MS
    [J]. CELL, 1981, 24 (02) : 493 - 502
  • [8] Effect of bafilomycin A1 and nocodazole on endocytic transport in HeLa cells: Implications for viral uncoating and infection
    Bayer, N
    Schober, D
    Prchla, E
    Murphy, RF
    Blaas, D
    Fuchs, R
    [J]. JOURNAL OF VIROLOGY, 1998, 72 (12) : 9645 - 9655
  • [9] BECK KA, 1991, J BIOL CHEM, V266, P4442
  • [10] Begley DJ, 2003, PROG DRUG RES, V61, P39